Skip to main content
. Author manuscript; available in PMC: 2022 Oct 13.
Published in final edited form as: Eur Heart J Digit Health. 2022 May 17;3(2):238–244. doi: 10.1093/ehjdh/ztac028

Table 1.

Baseline cohort characteristics with and without left ventricular systolic dysfunction

Age (95% CI) 63.6 (63.4, 63.7) 68.5 (68.0, 69.0)
Female (%) 18270 (44.5) 1082 (27.5)
Race (%)
 Non-Hispanic White 36601 (89.1) 3513 (89.4)
 Black 1810 (4.4) 206 (5.2)
 Other 2647 (6.4) 209 (5.3)
Hispanic (%) 1776 (4.3) 121 (3.1)
Congestive heart failure (%) 14530 (35.4) 3776 (95.9)
Myocardial infarction (%) 6498 (15.8) 1625 (41.4)
Hypertension (%) 27090 (66.0) 3066 (78.1)
Diabetes mellitus (%) 10283 (25.0) 1398 (35.6)
Renal disease (%) 11997 (29.2) 1806 (46.0)
Cerebrovascular disease (%) 8645 (21.1) 1055 (26.9)
Peripheral vascular disease (%) 16947 (41.3) 2611 (66.5)
COPD (%) 11613 (28.3) 1380 (35.1)
Connective tissue/rheumatologic disease (%) 2963 (7.2) 284 (7.2)
EF below 30% by TTE (%) 0 (0.0) 1848 (47.0%)
EF below 50% by TTE (%) 4262 (10.4) 3928 (100%)
*

CI, confidence interval; EF, ejection fraction; TTE, transthoracic echocardiogram